Nanotechnology Reviews (Nov 2024)
Toxicity assessment of copper oxide nanoparticles: In vivo study
Abstract
Copper oxide nanoparticles (CuO NPs) have wide range of application in many fields of industry, agriculture, cosmetics, and health care with probable risk to human health. The present study was conducted to find the chronic toxicity of these nanoparticles in the vital organs. Male healthy Wister Albino rats were subjected on daily bases to 35 intraperitoneal administration of 25 nm CuO NPs (2 mg/kg). All animals were subjected to morphological, histological, histochemical, and ultrastructural examinations. Exposure to CuO NPs induced reduction in body weight gain, urine retention, back arching, and renal calculi formation. The renal tissues demonstrated tubular hydropic degeneration, glomerular hypercellularity, blood vessels congestion and dilatation, renal interstitial oedema, mitochondrial injury, and lysosomal hypertrophy. Conversely, the liver displayed hepatocyte insultation, sinusoidal dilatation, Kupffer cells hyperplasia, inflammatory cell infiltration, hepatocytes mitochondrial cristolysis, mitochondrial swelling, lysosomal hyperplasia, and nuclear alterations. Furthermore, the cardiac tissues demonstrated congestion, cardiocytes disarray, and disorganization. In addition, the neural tissue exhibited Purkinje cells degeneration and cerebral cortex spongiosis. The results suggest that CuO nanomaterials engage with the vital organs’ components, potentially leading to alterations that could affect the organs function. Further research is encouraged for better understanding the mechanisms involved in pathogenesis of CuO NPs.
Keywords